SG Americas Securities
RPTP

SG Americas Securities’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

SG Americas Securities’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-110,829
Closed -$994K – 3764
2016
Q3 		$994K Buy
+110,829
New +$788K 0.01% 1177
2016
Q2 		– Sell
-24,140
Closed -$111K – 3336
2016
Q1 		$111K Buy
+24,140
New +$97K ﹤0.01% 2571
2015
Q4 		– Sell
-12,914
Closed -$78K – 3269
2015
Q3 		$78K Buy
12,914
+3,745
+41% +$45.9K ﹤0.01% 1919
2015
Q2 		$145K Buy
+9,169
New +$111K ﹤0.01% 2149
2015
Q1 		– Sell
-11,250
Closed -$118K – 3489
2014
Q4 		$118K Buy
11,250
+1,206
+12% +$11.8K ﹤0.01% 2808
2014
Q3 		$96K Buy
+10,044
New +$103K ﹤0.01% 2388
2013
Q4 		– Sell
-13,237
Closed -$198K – 3457
2013
Q3 		$198K Buy
+13,237
New +$159K ﹤0.01% 2191

SG Americas Securities's RPTP Position: Q4 2016 in Review

SG Americas Securities sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 110,829 shares — an estimated $994K sold.

SG Americas Securities first reported a position in RPTP in Q3 2013 and held it in 7 quarters. The position peaked at $994K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • SG Americas Securities reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • SG Americas Securities sold 110,829 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $994K.
  • SG Americas Securities first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 7 quarters.
  • SG Americas Securities's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $994K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on SG Americas Securities's 13F filing for Q4 2016, filed 8 Feb 2017.